Like the cycle plotter, this uses a one-compartment model with exponential elimination and dose superposition. The Y-axis is a relative level in arbitrary units — not ng/mL and not a clinical prediction.
Difference: each row has its own cycle length, so injections stop when that protocol ends while other compounds can continue — useful when stacking different on/off lengths. Depot behaviour is not auto-modeled: you supply the half-life and, for T-max, the day each dose peaks. A T-max above zero is modeled as first-order absorption, so the peak stays below the dose and total exposure is conserved; zero is an instant bolus. Because absorption cannot outrun elimination, T-max is capped at half-life ÷ ln 2, and the tool says so when you pass it.
Active dose (%) is the ester weight correction — the share of each milligram that is hormone — so stacking different esters compares like with like rather than raw milligrams.
The total line is the sum of relative curves; it does not rank potency or true plasma exposure across drugs. Take half-life and T-max from literature for each compound. Intramuscular PK is often multi-phase; treat this as an educational visualization.
Active dose is the ester weight correction — the share of each milligram that is hormone. From molecular weights: testosterone propionate ≈ 83.7%, enanthate ≈ 72%, cypionate ≈ 69.9%. Leave it at 100 to plot the dose exactly as injected.
Each compound has its own cycle length and injection schedule. The chart runs until the longest cycle ends plus five half-lives (washout).
One-compartment model with first-order absorption (Bateman) and superposition. Relative units — not clinical concentration.
Note: Outputs are mathematical estimates from a simplified model. Individual physiology is not represented.